Sepracor-Looks very promising Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Sepracor-Looks very promising

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Icebrg who wrote (6910)	5/27/2003 9:44:31 PM
From: Biomaven	Read Replies (2) of 10280

They could abandon Claritin, let Clarinex go OTC and finally keep Soltara as their prescription drug I'd be very surprised indeed if this were to happen. SGP isn't going to give up the 20+% of the antihistamine market held by Clarinex in exchange for a not-yet-approved drug. Also, the FTC would need quite a bit of convincing, which would cause unacceptable delay. I continue to believe that if SGP tried to buy SEPR at this stage they would have to immediately jettison Soltara. Doesn't mean it couldn't happen, but it is one strike against that particular deal. Personally I wouldn't be happy if SEPR were taken out just now. Of course I would have been a lot less happy if someone had made a play when the stock was in the low single digits. But trying to buy the company at that point would have been too smart for your average pharma. <g> My guess is that today was just a rumor by someone trying to squeeze a short or two. Peter

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next